On my way to Madrid for #ESC2025 -- I have to say this may be the best cardiology meeting in years. Shocking how many important trials there are I picked six to discuss, but there are many more: medscape.com/viewarticle/ma…

iacopo olivotto on Pregnancy in #HCM 🤰 with LVOTO ✔️ Assess basal risk ✔️ Pregnancy usually well-tolerated: hyperdinamic 🫀, hypervolemia is wellcome in HOCM 'stato di grazia' ✔️ BB ✅️, Disopyramide❌️ ✔️ Delivery may be challenging but CST is NOT the rule! #CardioObstetrics

#ESCCongress 2025 Brian Halliday on challenges in 🤰DCM ✔️frequent monitoring - serial #echofirst and NTproBNP ✔️ASAP return to GDMT after delivery ✔️ role of Bromocriptine: safety✅️, efficacy⁉️ - RCT on the way ✔️ genotype-specific risk stratification #CardioObstetrics

🚨 Live from #ESCCongress + now online in Circulation 🚨 ahajournals.org/eprint/IMVYICJ… Honored to present our work on Intermediate-Effect Variants (IEVs) in HCM, selected for the Young Investigator Award. 🏆 60% of HCM cases G (-). Maybe we’ve been looking in the wrong place… 👇🧵

#ESCCongress HOTLINE 2️⃣ ODYSSEY-HCM failed to reach its primary endpoint of increase in KCCQ and peak VO2 in non-obstructive #HCM Subgroup analysis suggest potential benefit ▶️ younger patients ▶️ less advanced disease and shorter duration of disease ▶️ less diastolic dysfunction

Great presentation of the MAPLE-HCM trial results by Pablo Garcia-Pavia Congratulations!!! CNIC #ESCCongress2025

#ESCCongress #HOTLINE 2 MAPLE-HCM w/ impressive results presented by Pablo Garcia-Pavia Are we headed to CMI as 1st line therapy for LVOTO⁉️ Aficamten was superior to Metoprolol in the primary endpoint of ⬆️pVO2 and ALL sec endpoints (NYHA, KCCQ, NTproBNP, LVOTO). Enhorabuena Pablo!

#ESCCongress HOTLINE 3 Borja Ibanez presents REBOOT-CNIC ❌️no differences in the composite primary endpoint with B-blockers after ACS with LVEF>40% ! ❗️Signal for potential benefit in the subgroup of LVEF 40-50% Impressive organization of 🇪🇸 centers! CNIC

#ESCCongress | Current challenges in #ATTR amyloidosis 🫀 Pablo Garcia-Pavia & marianna fontana raise hot topic points ✔️ #ATTR is not only about misfolding - slow clearance is key - 🆕️ depleters ✔️ prognosis has changed - RCT populations not comparable ✔️ era of combined therapy ahead⁉️

#ESCCongress special session with Casa de S.M. el Rey Felipe VI Rey de España What a great high point to a majestic congress hosted by Madrid and 🇪🇸. Honored to also be able call it one of my homes! European Society of Cardiology Sociedade Portuguesa de Cardiologia

#ESCCongress GENETIC MATTERS! Fernando Domínguez on genetic testing in #myocarditis 🧬 family hx of cardiomyopathies/ 'familial myocarditis' 🧬 high-risk CMR patterns -💍like pattern/septal LGE 🧬 recurrent episodes 🧬 severe episodes / slow recovery ❗️8% of cases w/ genetic background!!

#ESCCongress | time to put the badge down! This was a special one 💛Madrid 🇪🇸 was 🔝 set and it was great to host my 🇵🇹 friends So many 🔝 points: my #SoMe ambassador role, our unit Cardiología Puerta de Hierro🫀 on 🔥 with 🔝 science and major #LBT! Great networking with mentors and friends 💛❤️

👉Don’t miss the 2025 HCM A CORUÑA meeting!🇪🇸 💡 Latest updates on HCM, Amyloidosis & Fabry Disease with leading experts 🇪🇺🇺🇸🇦🇷🇦🇺🇬🇧 🗣️LATE-BREAKING NEWS: 🎥 VIRTUAL TICKETS NOW AVAILABLE!!! – join LIVE or ON DEMAND! 👉 Register today! hypertrophiccardiomyopathyacoruna.com

New #EACVI #HITbite by Mariana Brandão on: "Stepwise approach to LV hypertrophy" If you would to like learn more #CVImaging, don't miss the next #EACVI Webinar 22/09/25 18:00-19:00 CET on: "Stepwise approach to a thick ventricle – do not miss the red flags 🚩"

3D artifacts beautifully demonstrated by Luigi! ⚠️ Tip: Important content to review when prepararing for #EACVI TTE/TOE #echofirst certifications ‼️ Luna Gargani JP Carpenter Dr Mark Westwood Denisa Muraru EACVI President 🗓 Registration until 10/11 escardio.org/Education/Care…